6 completed, 4 unknown, 1 active not recruiting. 3 Phase 1, 3 Phase 4, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Unknown 1 |
| Phase 4 | 3 | Unknown 2, Completed 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Ranibizumab Injection: new trials by email Literature Review of Ranibizumab Injection trials Research Report on Ranibizumab Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabetic Retinopathy Ranibizumab Injection, PPV - Diabetic Retinopathy, Postoperative Recurrent Vitreous Hemorrhage | Phase 1 | Unknown | Tianjin Medical University Eye Hospital | 120 | 2022-04-10 | 2022-08-12 |
| Phase I Study to Compare CMAB818 Injection and Lucentis® in Patients With Wet AMD CMAB818, Lucentis® - Wet Age-related Macular Degeneration | Phase 1 | Completed | Shanghai Biomabs Pharmaceutical Co., Ltd. | 24 | 2021-06-03 | 2024-03-28 |
| Combination of Ranibizumab and Targeted Laser Photocoagulation Ranibizumab Injection, Laser photocoagulation - Central Retinal Vein Occlusion With Macular Edema | Phase 3 | Active not recruiting | University of Giessen | 88 | 2020-08-25 | 2026-05-08 |
| Anti-VEGF Therapy Versus Dexamethasone Implant for DME Aflibercept,, Ranibizumab Injection, Ozurdex Drug Implant Product - Clinically Significant Macular Edema Due to Diabetes Mellitus | Phase 4 | Unknown | Sudhalkar Eye Hospital | 150 | 2019-06-25 | 2019-06-26 |
| OCTA and Polypoidal Choroidal Vasculopathy Ranibizumab Injection - Polypoidal Choroidal Vasculopathy | Completed | Federico II University | 60 | 2019-01-15 | 2021-01-19 | |
| Evaluating of the Safety, Pharmacokinetics and Pharmacodynamics of QL1205 and Lucentis® in Patients With Wet AMD lucentis, QL1205 - Wet Age-related Macular Degeneration | Phase 1 | Completed | Qilu Pharmaceutical Co., Ltd. | 48 | 2017-12-20 | 2019-04-11 |
| Ranibizumab Versus Dexamethasone Implant in Diabetic Macular Edema Dexamethasone intravitreal implant 0.7 mg, Ranibizumab Injection - Diabetic Macular Edema | Completed | G. d'Annunzio University | 40 | 2016-12-06 | 2018-01-02 | |
| Ranibizumab Plus Indomethacin Ranibizumab Injection, Indomethacin - Macular Edema | Phase 4 | Completed | Università degli Studi di Brescia | 58 | 2016-01-07 | 2017-08-25 |
| Evaluation of Retinal and Vascular Features in Coats Disease After Intravitreal Injections of Ranibizumab Ranibizumab Injection - Coats Disease | Completed | Federico II University | 5 | 2016-01-01 | 2020-03-17 | |
| Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD) Ranibizumab, Ranibizumab Injection - Age-Related Macular Degeneration | Not applicable | Unknown | Russian Academy of Medical Sciences | 300 | 2011-10-01 | 2012-08-31 |
| Ranibizumab for Myopic Neovascularization ranibizumab injection - Myopic Choroidal Neovascularization | Phase 4 | Unknown | Instituto de Olhos de Goiania | 20 | 2009-07-01 | 2014-01-01 |
Diabetic Retinopathy (1) · Macular Degeneration (1) · Macular Edema (1) · Myopia (1) · Neovascularization, Pathologic (1) · Polypoidal Choroidal Vasculopathy (1) · Retinal Telangiectasis (1) · Retinal Vein Occlusion (1)
Federico II University (2) · G. d'Annunzio University (1) · Instituto de Olhos de Goiania (1) · Qilu Pharmaceutical Co., Ltd. (1) · Russian Academy of Medical Sciences (1) · Shanghai Biomabs Pharmaceutical Co., Ltd. (1) · Sudhalkar Eye Hospital (1) · Tianjin Medical University Eye Hospital (1) · University of Giessen (1) · Università degli Studi di Brescia (1)
China (3) · Germany (2) · Italy (2) · Austria (1) · Brazil (1) · Russia (1)
Gilda Cennamo (2) · Daniela Montorio (1) · Mariya Budzinskaya, MD, PhD (1) · Matus Rehak, Professor (1) · Wenbin Wei, PhD (1) · Xiuli Zhao, PhD (1) · Xun Xu, professor (1)